1-Cyclohex-2-en-1-ylethanamine | 40391-20-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-Cyclohex-2-en-1-ylethanamine
• CAS: 40391-20-6
• 化学式: C₈H₁₅N
• mdl: MFCD19210274
• 分子量: 125.214
• InChiKey: ZXCMYUNDMRJEAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-Cyclohex-2-en-1-ylethanamine 、 氯甲酸乙酯 生成
  参考文献：
  名称：

  Ag+-catalyzed rearrangements. XIII. Mechanistic aspects of the silver(I)-promoted rearrangements of tricyclo[4.1.0.02,7]heptane derivatives. Deuterium isotope effect studies and independent generation of argento carbonium ions

  摘要：

  DOI：

  10.1021/ja00777a020
• 作为产物：
  描述：

  生成 1-Cyclohex-2-en-1-ylethanamine
  参考文献：
  名称：

  Ag+-catalyzed rearrangements. XIII. Mechanistic aspects of the silver(I)-promoted rearrangements of tricyclo[4.1.0.02,7]heptane derivatives. Deuterium isotope effect studies and independent generation of argento carbonium ions

  摘要：

  DOI：

  10.1021/ja00777a020

文献信息

• COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES
  申请人：Vasudevan Anil

  公开号：US20100035919A1

  公开（公告）日：2010-02-11

  Disclosed herein are compounds of formula (I) or pharmaceutical acceptable salts thereof, wherein A, X 1 , X 2 , R 1 , R 2 , R 3 , m, n, and p are defined in the specification. Compositions including the compounds which can be useful for inhibiting Rho kinase (ROCK) and methods for using the compositions are also described.

  本文披露了式（I）的化合物或其药用可接受的盐，其中A、X1、X2、R1、R2、R3、m、n和p在规范中有定义。还描述了包括这些化合物的组合物，这些组合物可用于抑制Rho激酶（ROCK），并描述了使用这些组合物的方法。
• SELENOPHENE COMPOUNDS
  申请人：Shia Kak-Shan

  公开号：US20080021031A1

  公开（公告）日：2008-01-24

  This invention relates to selenophene compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

  这项发明涉及下面所示的化学式（I）的硒吡咯烯化合物。化学式（I）中的每个变量在说明书中有定义。这些化合物可以用于治疗大麻素受体介导的疾病。
• Amidobenzamide derivatives which are useful as cytokine inhibitors
  申请人：Brown S. Dearg

  公开号：US20050038081A1

  公开（公告）日：2005-02-17

  The invention concerns amide derivatives of the Formula (I) wherein R 3 is (1-6C)alkyl or halogeno; Q is aryl or heteroaryl which optionally bears 1, 2, 3 or 4 substituents such as hydroxy, halogeno, trifluoromethyl, cyano, (1-6C)alkyl, (1-6C)alkoxy, halogeno-(1-6C)alkyl, hydroxyl-(1-6C)alkyl, di-[(1-6C)akly]amino-(1-6C)alkyl, hydroxy-(2-6C)alkoxy, (1-6C)alkoxy-(2-6C)alkoxy, di-[(1-6C)alkyl]amino-(2-6C)alkoxy, amino(2-6C)alkylamino, N-(1-6C)alkyl-(1-6C)alkylamino-(2-6C)alkylamino, aryl, aryl-(1-6C)alkoxy, heteroaryl, heteroaryl-(1-6C)alkoxy, heterocyclyl, heterocyclyl-(1-6C)alkyl, heterocyclyloxy and heterocyclyl-(1-6C)alkoxy; p is 0-2 and R 2 is a substituent such as hydroxy and halogeno; q is 0-4; and R 4 includes optionally substituted aryl, cycloalkyl, heteroaryl and heterocyclyl; or pharmaceutically-acceptable salts or in-vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.

  本发明涉及公式（I）的酰胺衍生物，其中R3是（1-6C）烷基或卤素基; Q是芳基或杂环芳基，其可选地带有1、2、3或4个取代基，例如羟基、卤素基、三氟甲基、氰基、（1-6C）烷基、（1-6C）烷氧基、卤代（1-6C）烷基、羟基（1-6C）烷基、二-[(1-6C)烷基]氨基（1-6C）烷基、羟基（2-6C）烷氧基、（1-6C）烷氧基（2-6C）烷氧基、二-[(1-6C)烷基]氨基（2-6C）烷氧基、氨基（2-6C）烷基氨基、N-(1-6C)烷基-(1-6C)烷基氨基-(2-6C)烷基氨基、芳基、芳基-(1-6C)烷氧基、杂环芳基、杂环芳基-(1-6C)烷氧基、杂环基、杂环基-(1-6C)烷基、杂环氧基和杂环基-(1-6C)烷氧基; p为0-2，R2是羟基和卤素基等取代基; q为0-4; R4包括可选的取代芳基、环烷基、杂环芳基和杂环基; 或其药学上可接受的盐或体内可水解的酯; 以及制备它们的方法、包含它们的制药组合物以及它们在治疗由细胞因子介导的疾病或医疗条件中的用途。
• NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：Lee Cheol Hae

  公开号：US20100069630A1

  公开（公告）日：2010-03-18

  The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.

  本发明公开了一种新型萘氧基丙烯酰衍生物，用于抑制组蛋白去乙酰化酶的酶活性，从而有效抑制癌细胞增殖。
• Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
  申请人：Korea Research Institute Of Chemical Technology

  公开号：EP2913322A2

  公开（公告）日：2015-09-02

  The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacctylase, leading effective suppression of cancer cell proliferation.

  本发明公开了新型萘氧丙烯基衍生物，可用于抑制组蛋白脱切酶的酶活性，从而有效抑制癌细胞增殖。